Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 23Terminated 4Unknown 1Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 2Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 9Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Hematologic Neoplasms 4Lymphoma, T-Cell, Peripheral 3Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Hodgkin Disease 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Spondylolisthesis 1Spinal Stenosis 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Small Cell Lung Carcinoma × Lymphoid × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡